This website uses non-intrusive cookies to improve your user experience. You can visit our cookie privacy page for more information.

Beta This is a new way of showing guidance - your feedback will help us improve it.

RR1074 - Costs to Britain of Work-Related Cancer

Understanding the economic and wider impacts of work-related cancer is important to inform HSE’s regulatory decision making and engagement with stakeholders on the case for proportionate risk management in the workplace. Monetised estimates are used by HSE in Regulatory Impact Assessments and other evaluations and economic analyses.

This report presents new research which estimates in monetary terms the total annual economic burden of new cases of work-related cancer in Great Britain (GB) in 2010. It is the first attempt at such an estimate and provides the most comprehensive indicator of the overall burden on society available. The analysis accounts for a broad range of impacts from work-related cancer and how the costs fall to different groups: individuals, employers, government, and society as a whole. Costs are estimated for the 24 work-related cancer types identified in the HSE Cancer Burden Study, which was published in 2010, based on both the known and the probable carcinogens classified by the International Agency for Research on Cancer.

The results suggest that the total economic costs of new cases of work-related cancer in GB in 2010, arising from past working conditions, were around £12.3 billion. Individuals bear the vast majority of the costs of work-related cancer.

Assistance in the use of Adobe Acrobat PDF files is available on our FAQs page.

Updated 2019-09-20